Department of Anesthesiology, University of California San Diego, La Jolla, California, USA.
Anesth Analg. 2011 Oct;113(4):897-903. doi: 10.1213/ANE.0b013e318212495b. Epub 2011 Apr 5.
BACKGROUND: Hip arthroplasty frequently requires potent postoperative analgesia, often provided with an epidural or posterior lumbar plexus local anesthetic infusion. However, American Society of Regional Anesthesia guidelines now recommend against epidural and continuous posterior lumbar plexus blocks during administration of various perioperative anticoagulants often administered after hip arthroplasty. A continuous femoral nerve block is a possible analgesic alternative, but whether it provides comparable analgesia to a continuous posterior lumbar plexus block after hip arthroplasty remains unclear. We therefore tested the hypothesis that differing the catheter insertion site (femoral versus posterior lumbar plexus) after hip arthroplasty has no impact on postoperative analgesia. METHODS: Preoperatively, subjects undergoing hip arthroplasty were randomly assigned to receive either a femoral or a posterior lumbar plexus stimulating catheter inserted 5 to 15 cm or 0 to 1 cm past the needle tip, respectively. Postoperatively, patients received perineural ropivacaine, 0.2% (basal 6 mL/hr, bolus 4 mL, 30-minute lockout) for at least 2 days. The primary end point was the average daily pain scores as measured with a numeric rating scale (0-10) recorded in the 24-hour period beginning at 07:30 the morning after surgery, excluding twice-daily physical therapy sessions. Secondary end points included pain during physical therapy, ambulatory distance, and supplemental analgesic requirements during the same 24-hour period, as well as satisfaction with analgesia during hospitalization. RESULTS: The mean (SD) pain scores for subjects receiving a femoral infusion (n = 25) were 3.6 (1.8) versus 3.5 (1.8) for patients receiving a posterior lumbar plexus infusion (n = 22), resulting in a group difference of 0.1 (95% confidence interval -0.9 to 1.2; P = 0.78). Because the confidence interval was within a prespecified -1.6 to 1.6 range, we conclude that the effect of the 2 analgesic techniques on postoperative pain was equivalent. Similarly, we detected no differences between the 2 treatments with respect to the secondary end points, with one exception: subjects with a femoral catheter ambulated a median (10th-90th percentiles) 2 (0-17) m the morning after surgery, in comparison with 11 (0-31) m for subjects with a posterior lumbar plexus catheter (data nonparametric; P = 0.02). CONCLUSIONS: After hip arthroplasty, a continuous femoral nerve block is an acceptable analgesic alternative to a continuous posterior lumbar plexus block when using a stimulating perineural catheter. However, early ambulatory ability suffers with a femoral infusion.
背景:髋关节置换术常需要强效的术后镇痛,通常通过硬膜外或后路腰椎丛局部麻醉输注来实现。然而,美国区域麻醉学会指南现在建议在髋关节置换术后使用各种围手术期抗凝剂时避免使用硬膜外和连续后路腰椎丛阻滞。连续股神经阻滞是一种可能的替代镇痛方法,但它在髋关节置换术后提供的镇痛效果是否与连续后路腰椎丛阻滞相当仍不清楚。因此,我们假设髋关节置换术后改变导管插入部位(股部与后路腰椎丛)不会对术后镇痛产生影响。
方法:术前,接受髋关节置换术的患者被随机分配接受股部或后路腰椎丛刺激导管插入,分别插入距针尖 5 至 15 厘米或 0 至 1 厘米处。术后,患者接受股神经周围罗哌卡因 0.2%(基础量 6 毫升/小时,推注 4 毫升,30 分钟锁定)至少 2 天。主要终点是在术后 07:30 开始的 24 小时内,使用数字评分量表(0-10)记录的平均每日疼痛评分,不包括每日两次的物理治疗。次要终点包括物理治疗期间的疼痛、活动距离以及同一 24 小时内的辅助镇痛需求,以及住院期间的镇痛满意度。
结果:接受股部输注的患者(n=25)的平均(SD)疼痛评分(3.6[1.8])与接受后路腰椎丛输注的患者(n=22)的疼痛评分(3.5[1.8])相同,组间差异为 0.1(95%置信区间 -0.9 至 1.2;P=0.78)。由于置信区间在预定的 -1.6 至 1.6 范围内,我们得出结论,两种镇痛技术对术后疼痛的影响是等效的。同样,我们没有发现两种治疗方法在次要终点上有差异,只有一个例外:接受股部导管的患者在术后早晨的中位(10 至 90 百分位数)步行距离为 2(0-17)米,而接受后路腰椎丛导管的患者为 11(0-31)米(数据非参数;P=0.02)。
结论:在髋关节置换术后,使用刺激型外周神经导管时,连续股神经阻滞是连续后路腰椎丛阻滞的一种可接受的替代镇痛方法。然而,股部输注会导致早期活动能力受损。
Clin Orthop Relat Res. 2014-5
Comput Math Methods Med. 2022
Reg Anesth Pain Med. 2016